Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circular RNAs in cell cycle regulation: Mechanisms to clinical significance. | Cell Prolif | 2021 | 34672397 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor. | Int J Biol Sci | 2021 | 34671197 | PubTator, text mining | PubMed |
| IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women. | NPJ Breast Cancer | 2021 | 34671036 | PubTator, text mining | PubMed |
| Extracellular vesicles in pancreatic cancer progression and therapies. | Cell Death Dis | 2021 | 34671031 | PubTator, text mining | PubMed |
| Debris-stimulated tumor growth: a Pandora's box? | Cancer Metastasis Rev | 2021 | 34665387 | PubTator, text mining | PubMed |
| Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis. | Bioengineered | 2021 | 34657558 | PubTator, text mining | PubMed |
Circular RNA erythrocyte membrane protein band 4.1 assuages ultraviolet irradiation-induced apoptosis of lens epithelial cells by stimulating 5'-bisphosphate nucleotidase 1 in a miR-24-3p-dependent manner. | Bioengineered | 2021 | 34652259 | PubTator, text mining | PubMed |
| CircularRNA_0119872 regulates the microRNA-582-3p/E2F transcription factor 3 pathway to promote the progression of malignant melanoma. | Clinics (Sao Paulo) | 2021 | 34644734 | PubTator, text mining | PubMed |
| Differential Marker Expression between Keratinocyte Stem Cells and Their Progeny Generated from a Single Colony. | Int J Mol Sci | 2021 | 34639148 | PubTator, text mining | PubMed |
| RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways. | Cancers (Basel) | 2021 | 34638509 | PubTator, text mining | PubMed |
| Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature. | Cancers (Basel) | 2021 | 34638377 | PubTator, text mining | PubMed |
| The Functional Role of Long Non-Coding RNAs in Melanoma. | Cancers (Basel) | 2021 | 34638331 | PubTator, text mining | PubMed |
| Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential. | Cancers (Basel) | 2021 | 34638282 | PubTator, text mining | PubMed |
Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group. | Cancers (Basel) | 2021 | 34638247 | PubTator, text mining | PubMed |
| Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis. | BMC Genom Data | 2021 | 34635059 | PubTator, text mining | PubMed |
| Emerging Advances of Non-coding RNAs and Competitive Endogenous RNA Regulatory Networks in Asthma. | Bioengineered | 2021 | 34635022 | PubTator, text mining | PubMed |
| Thyroid Transcription Factor-1: Structure, Expression, Function and Its Relationship with Disease. | Biomed Res Int | 2021 | 34631891 | PubTator, text mining | PubMed |
| Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in human aortic dissection. | BMC Genomics | 2021 | 34620091 | PubTator, text mining | PubMed |
| Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma. | Bioengineered | 2021 | 34617871 | PubTator, text mining | PubMed |
| CircRNAs: a family number of miRNA regulatory transcriptome in laryngeal carcinoma. | J Clin Lab Anal | 2021 | 34617636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=46